Evigrade
Major

Haloperidol × tacrolimus

First-generation antipsychotics. Butyrophenone derivatives×Calcineurin inhibitor (immunosuppressant)

Mechanism

Additive QT prolongation. Haloperidol strongly prolongs QT, especially parenterally (IV). Tacrolimus prolongs QT with hypomagnesaemia. Combined action raises torsades de pointes risk.

Symptoms

QT prolongation on ECG, dizziness, syncope, palpitations. Severe cases: polymorphic ventricular tachycardia (torsades de pointes). Risk is higher with hypokalaemia and hypomagnesaemia.

Management

Avoid the combination, especially IV haloperidol. Alternative antipsychotics with minimal QT effect post-transplant: olanzapine or aripiprazole. For acute delirium: dexmedetomidine (no QT effect).

Sources

All interactions

Haloperidol and tacrolimus: interaction, management, sources – Evigrade